S-OtrH3N2 viruses: Use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses

Eurosurveillance

Volumn 16, Issue 50, 2011, Pages

  Lina, B ^a,b   Bouscambert, M ^a   Enouf, V ^c   Rousset, D ^c   Valette, M ^a   van der Werf, S ^c,d,e,f  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSTITUT PASTEUR   (France)

^d Sorbonne Paris Cité   (France)

^e CNRS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; CROSS PROTECTION; GENETIC REASSORTMENT; HUMAN; INFLUENZA A H1N1 PDM09 VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR GENETICS; NONHUMAN; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S OTRH3N2 VIRUS; SEQUENCE ANALYSIS; SWINE INFLUENZA; SWINE INFLUENZA VIRUS; UNITED STATES; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 84855319058     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention (CDC). Limited human-to-human transmission of novel influenza A (H3N2) virus-Iowa, November 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1615-7.
2. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, et al. Triple reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med. 2009;360(25):2616-25.
3. Brockwell-Staats C, Webster RG, Webby RJ. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respi Viruses. 2009;3(5):207-13.
4. Shu B, Garten R, Emery S, Balish A, Cooper L, Sessions W, et al. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology. 2012;422(1):151-60.
5. Centers for Disease Control and Prevention (CDC). "Have You Heard?" CDC confirms two human infections with novel influenza viruses. Atlanta: CDC; 9 Dec 2011. Available from: http://www.cdc.gov/media/haveyouheard/stories/novel_influenza.html
6. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol. 2011;28(10):2731-9.
7. Suwannakarn K, Chieochansin T, Thongmee C, Makkoch J, Praianantathavorn K, Theamboonlers A, et al. Molecular evolution of human H1N1 and H3N2 influenza A virus in Thailand, 2006-2009. PLoS One. 2010;5(3):e9717.
8. Koel BF, Burke DF, Bestebroer TM, Van der Vliet S, Vervaet G, Skepner E, et al. 35 years of antigenic evolution of Influenza A/ H3N2 virus is dictated by 7 aminoacid positions flanking the hemagglutinin receptor binding site. The fourth ESWI influenza conference; 11-14 Sept 2011; Malta.
9. Sponseller BA, Strait E, Jergens A, Trujillo J, Harmon K, Koster L, et al. Influenza A Pandemic (H1N1) 2009 Virus Infection in Domestic Cat. Emerg Infect Dis. 2010;16(3):534-7.
10. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375(9720):1100-8.